Search Result "bortezomib-binding"


Focal Adhesion Kinase as a Therapeutic Target of Bortezomib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 747-752
Author(s): Bor-Sheng Ko, Tzu-Ching Chang, Jun-Yang Liou

Progress of Computer-Aided Drug Design (CADD) of Proteasome Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2011 Page: 2931-2944
Author(s): Meng Lei, Yunde Liu, Yongqiang Zhu, Zhenming Liu

Proteasome Inhibition in Hematological Malignancies

Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Guilherme Augusto Silva dos Santos
Doi: 10.2174/978160805259211201010034

Role of Immunomodulatory Drugs in the Treatment of Lymphoid and Myeloid Malignancies

Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 3 Year: 2018
Author(s): Ota Fuchs
Doi: 10.2174/9781681083674118030005

Novel Agents in the Management of Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4291-4325
Author(s): B. Kennedy, F. Gargoum, B. Bystricky, D. R. Curran, T. M. OConnor

General Review Article

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 51-78
Author(s): Ota Fuchs

The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2011 Page: 242-246
Author(s): James J. Driscoll, Alex Minter, Daniel A. Driscoll, Jason K. Burris

Research Article open access plus

Docking Simulations Exhibit Bortezomib and other Boron-containing Peptidomimetics as Potential Inhibitors of SARS-CoV-2 Main Protease

Journal: Current Chemical Biology
Volume: 14 Issue: 4 Year: 2020 Page: 279-288
Author(s): Iván R Vega-Valdez,Rosalez Melvin N.,Santiago-Quintana José M.,Farfán-García Eunice D.,Soriano-Ursúa Marvin A.

Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma

Journal: Clinical Cancer Drugs
Volume: 2 Issue: 1 Year: 2015 Page: 44-53
Author(s): Karen E. Thudium,Lance Wollenberg,Cory Mavis,Jenny Gu,Gerald J. Fetterly,Myron S. Czuczman,Francisco J. Hernandez-Ilizaliturri

Cancer Therapeutic Agents Targeting Hypoxia-Inducible Factor-1

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3168-3189
Author(s): R. Wang, S. Zhou, S. Li

Previous   Next

Go To   Results 1 - 1 of 874

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy